Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)
INR 210.7
(4.9%)
INR 210.7
(4.9%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 8.49 INR | -16.76% |
| 2022 | 10.20 INR | 41.67% |
| 2021 | 7.20 INR | 10.6% |
| 2020 | 6.51 INR | 117.0% |
| 2019 | 3.00 INR | 9.09% |
| 2018 | 2.75 INR | 162.36% |
| 2017 | -4.41 INR | -197.35% |
| 2016 | 4.53 INR | 265.32% |
| 2015 | 1.24 INR | 175.56% |
| 2014 | 0.45 INR | -44.44% |
| 2013 | 0.81 INR | 15.71% |
| 2012 | 0.70 INR | -75.44% |
| 2011 | 2.85 INR | 4.01% |
| 2010 | 2.74 INR | -27.13% |
| 2009 | 3.76 INR | 60.0% |
| 2008 | 2.35 INR | 100.85% |
| 2007 | 1.17 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 2.01 INR | 53.44% |
| 2024 Q2 | 4.29 INR | 113.43% |
| 2023 Q1 | 2.85 INR | 33.18% |
| 2023 Q2 | 2.85 INR | 0.0% |
| 2023 Q3 | 1.51 INR | -47.02% |
| 2023 FY | - INR | -16.76% |
| 2023 Q4 | 1.31 INR | -13.25% |
| 2022 Q3 | 2.97 INR | -25.19% |
| 2022 Q1 | 1.12 INR | 11689.47% |
| 2022 FY | - INR | 41.67% |
| 2022 Q4 | 2.14 INR | -27.95% |
| 2022 Q2 | 3.97 INR | 254.46% |
| 2021 Q4 | 0.01 INR | -99.53% |
| 2021 FY | - INR | 10.6% |
| 2021 Q3 | 2.02 INR | -19.52% |
| 2021 Q2 | 2.51 INR | -3.83% |
| 2021 Q1 | 2.61 INR | 33.85% |
| 2020 FY | - INR | 117.0% |
| 2020 Q3 | 2.07 INR | 35.29% |
| 2020 Q2 | 1.53 INR | 59.38% |
| 2020 Q1 | 0.96 INR | 62.71% |
| 2020 Q4 | 1.95 INR | -5.8% |
| 2019 Q4 | 0.59 INR | -32.18% |
| 2019 FY | - INR | 9.09% |
| 2019 Q1 | 0.76 INR | -33.33% |
| 2019 Q3 | 0.87 INR | 12.99% |
| 2019 Q2 | 0.77 INR | 1.32% |
| 2018 Q1 | 0.28 INR | 159.57% |
| 2018 Q2 | 0.68 INR | 142.86% |
| 2018 Q3 | 0.67 INR | -1.47% |
| 2018 Q4 | 1.14 INR | 70.15% |
| 2018 FY | - INR | 162.36% |
| 2017 Q1 | -1.61 INR | -619.35% |
| 2017 Q4 | -0.47 INR | 45.35% |
| 2017 Q3 | -0.86 INR | 41.5% |
| 2017 Q2 | -1.47 INR | 8.7% |
| 2017 FY | - INR | -197.35% |
| 2016 Q1 | 0.24 INR | -68.42% |
| 2016 FY | - INR | 265.32% |
| 2016 Q2 | 0.19 INR | -20.83% |
| 2016 Q3 | 3.78 INR | 1889.47% |
| 2016 Q4 | 0.31 INR | -91.8% |
| 2015 FY | - INR | 175.56% |
| 2015 Q4 | 0.76 INR | 484.62% |
| 2015 Q3 | 0.13 INR | -23.53% |
| 2015 Q2 | 0.17 INR | -5.56% |
| 2015 Q1 | 0.18 INR | 617.13% |
| 2014 Q3 | 0.01 INR | -92.86% |
| 2014 Q2 | 0.14 INR | -48.15% |
| 2014 Q1 | 0.27 INR | -42.55% |
| 2014 FY | - INR | -44.44% |
| 2014 Q4 | 0.03 INR | 151.0% |
| 2013 Q1 | 0.00 INR | -98.92% |
| 2013 Q2 | 0.00 INR | 64.29% |
| 2013 Q4 | 0.47 INR | 38.24% |
| 2013 Q3 | 0.34 INR | 14682.61% |
| 2013 FY | - INR | 15.71% |
| 2012 Q1 | 0.00 INR | 0.0% |
| 2012 Q2 | 0.16 INR | 79900.0% |
| 2012 Q3 | 0.41 INR | 156.25% |
| 2012 Q4 | 0.13 INR | -68.29% |
| 2012 FY | - INR | -75.44% |
| 2011 FY | - INR | 4.01% |
| 2011 Q3 | 0.89 INR | -8.25% |
| 2011 Q2 | 0.97 INR | 0.0% |
| 2011 Q4 | - INR | -100.0% |
| 2010 FY | - INR | -27.13% |
| 2009 FY | - INR | 60.0% |
| 2008 FY | - INR | 100.85% |
| 2007 FY | - INR | 0.0% |